{"id":1595,"date":"2011-10-29T09:00:28","date_gmt":"2011-10-29T13:00:28","guid":{"rendered":"http:\/\/www.Centives.net\/S\/?p=1595"},"modified":"2011-10-29T02:50:22","modified_gmt":"2011-10-29T06:50:22","slug":"expiring-patents-will-give-many-cheaper-medicine","status":"publish","type":"post","link":"http:\/\/www.Centives.net\/S\/2011\/expiring-patents-will-give-many-cheaper-medicine\/","title":{"rendered":"Expiring Patents Will Give Many Cheaper Medicine"},"content":{"rendered":"<p><img decoding=\"async\" src=\"http:\/\/weblogs.baltimoresun.com\/health\/prescription%20drugs.jpg\" alt=\"\" width=\"95%\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>According to <em><a href=\"http:\/\/articles.boston.com\/2011-07-25\/business\/29813405_1_generic-brand-name-drugs-prescription-drugs\">Boston<\/a><\/em>, over the next year many people in the United States will start paying a good deal less for prescription drugs. Patents on several of the most purchased drugs will be expiring soon; this means that patients will be able to buy chemically equivalent non-brand name medicine. Some of the figures from the article are:<\/p>\n<ul>\n<li>The average generic prescription cost $72 whereas the average brand name cost $198<\/li>\n<li>15% of the population will be affected by these soon to expire patents<\/li>\n<li>In 2 years a brand name drug can lose 90% of it&#8217;s revenue to competition<\/li>\n<\/ul>\n<div>For more about what the changes will mean for the companies and consumers you can head <em><a href=\"http:\/\/articles.boston.com\/2011-07-25\/business\/29813405_1_generic-brand-name-drugs-prescription-drugs\">here<\/a><\/em>.<\/div>\n<div>Source: <em><a href=\"http:\/\/articles.boston.com\/2011-07-25\/business\/29813405_1_generic-brand-name-drugs-prescription-drugs\">Boston<\/a><\/em><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; According to Boston, over the next year many people in the United States will start paying a good deal less for prescription drugs. Patents on several of the most purchased drugs will be expiring soon; this means that patients will be able to buy chemically equivalent non-brand name medicine. Some of the figures from [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1595","post","type-post","status-publish","format-standard","hentry","category-daily-bulletin"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/posts\/1595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/comments?post=1595"}],"version-history":[{"count":3,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/posts\/1595\/revisions"}],"predecessor-version":[{"id":1598,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/posts\/1595\/revisions\/1598"}],"wp:attachment":[{"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/media?parent=1595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/categories?post=1595"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.Centives.net\/S\/wp-json\/wp\/v2\/tags?post=1595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}